Anzor Pharmaceuticals Selected to Present at the Prestigious BioLabs-NYU Investor & Innovator Exchange
FGF TECHNOLOGY REPRESENTS MAJOR BREAKTHROUGH IN METABOLIC AND CANCER DISEASES Boston, MA – May 6, 2025 – Anzor Pharmaceuticals is honored to announce its selection as a presenting company at the 2025 BioLabs-NYU Investor & Innovator Exchange, taking place on May 6, 2025, in New York City. This high-profile event, now in its second year, […]
